Dihydroergotamine Mesylate
Who holds supplier records for Dihydroergotamine Mesylate? 4 organisations hold a current record for Dihydroergotamine Mesylate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (2), Netherlands (1) and Czech Republic (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dihydroergotamine Mesylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dihydroergotamine-mesylate
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 3 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dihydroergotamine Mesylate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- OLON SPAItaly Company GMP cert on recordActive DMF 30497, 33022 · latest filing Sept 2018
- CURIA ITALY SRLItalyCEP Company GMP cert on recordActive DMF 22407 · latest filing Jan 2009
- TAPI NL BVNetherlandsActive DMF 14944 · latest filing Jun 2000
- TAPI Czech Industries s.r.oCzech RepublicCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (2)
Certificates of Suitability on the EDQM register for Dihydroergotamine Mesylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI CZECH INDUSTRIES S.R.O. Opava | CZ | CEP 2005-107 - Rev 03 Dihydroergotamine mesilate | Feb 2025 | Inspected Oct 2024 Czechia |
| CURIA ITALY S.R.L. Rozzano, Milano | IT | R1-CEP 2000-183 - Rev 08 Dihydroergotamine mesilate | Mar 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Dihydroergotamine Mesylate are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- Slovenia · Inactive DMF 16194 · filed Oct 2002
- Germany · Inactive DMF 10242 · filed Apr 1993
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Dihydroergotamine Mesylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200517).
Chemical identity
- IUPAC name
- (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
- Canonical SMILES
- C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O
- InChIKey
- ADYPXRFPBQGGAH-UMYZUSPBSA-N
- Synonyms
- D.h.e. 45, DHE-45, Diergo, Dihydergot, Dihydroergotamine mesilate, Dihydroergotamine mesylate, Dihydroergotamine mesylate component of embolex, Dihydroergotamine methanesulfonate, Migranal, NSC-759848, Tonopan, Trudhesa
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Ergotamine Derivative
- Chemical structure
- Ergotamines
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dihydroergotamine Mesylate?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Dihydroergotamine Mesylate: OLON SPA (Italy), CURIA ITALY SRL (Italy), TAPI NL BV (Netherlands) and TAPI Czech Industries s.r.o (Czech Republic). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dihydroergotamine Mesylate Drug Master Files are active?
OLON SPA (DMF 30497, 33022), CURIA ITALY SRL (DMF 22407) and TAPI NL BV (DMF 14944). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dihydroergotamine Mesylate records mean?
2 organisations have only inactive Type II DMFs for Dihydroergotamine Mesylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Dihydroergotamine Mesylate have a European Certificate of Suitability?
Yes. 2 organisations hold a valid CEP for Dihydroergotamine Mesylate on the EDQM register, including TAPI CZECH INDUSTRIES S.R.O. Opava (CZ) and CURIA ITALY S.R.L. Rozzano, Milano (IT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Dihydroergotamine Mesylate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dihydroergotamine Mesylate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.